ReviewEssays in biochemistry2025
Hijacking the Ubl code: bacterial manipulation of ubiquitin-like proteins.
Review in Essays in biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ubiquitin (Ub) and Ub-like (Ubl) signaling processes regulate broad aspects of eukaryotic cellular biology. Conserved sets of enzymes control the covalent attachment of Ub/Ubl onto proteins, and disruption of these highly regulated processes contributes to diseases including cancer and neurodegeneration. Aspects of Ub/Ubl signaling are central to the innate immune response to infectious pathogens. As such, pathogens such as viruses and bacteria have evolved sophisticated mechanisms to hijack and dysregulate the homeostasis of Ub/Ubl signaling. Pathogenic manipulation of the host Ub system is well studied, with multiple classes of secreted bacterial effector proteins discovered that regulate either Ub itself or the enzymes required for substrate ubiquitylation. While much less is known about the control of host Ubl signaling processes by pathogens, recent discoveries indicate that they, too, are hijacked during infection. The number of Ubl manipulators secreted by bacterial pathogens is likely to increase in the coming years as methods to identify and characterize bacterial effectors advance. This review highlights the current knowledge on bacterial manipulation of Ubl signaling, including SUMO, NEDD8, ISG15, UFM1, FAT10, and LC3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.